Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALDX |
---|---|---|
09:32 ET | 7598 | 3.41 |
09:34 ET | 3595 | 3.43 |
09:36 ET | 1200 | 3.45 |
09:38 ET | 800 | 3.445 |
09:41 ET | 200 | 3.43 |
09:45 ET | 800 | 3.41 |
09:48 ET | 3948 | 3.38 |
09:50 ET | 1284 | 3.39 |
09:52 ET | 9944 | 3.39 |
09:54 ET | 1408 | 3.39 |
09:59 ET | 1000 | 3.3892 |
10:01 ET | 7600 | 3.36 |
10:03 ET | 10799 | 3.38 |
10:12 ET | 300 | 3.38 |
10:14 ET | 100 | 3.38 |
10:19 ET | 200 | 3.39 |
10:21 ET | 500 | 3.39 |
10:24 ET | 500 | 3.38 |
10:26 ET | 850 | 3.39 |
10:28 ET | 1725 | 3.38 |
10:30 ET | 305 | 3.37 |
10:32 ET | 517 | 3.369 |
10:35 ET | 2436 | 3.335 |
10:37 ET | 415 | 3.33 |
10:44 ET | 669 | 3.34 |
10:50 ET | 100 | 3.34 |
10:51 ET | 4200 | 3.34 |
10:53 ET | 548 | 3.34 |
11:00 ET | 2829 | 3.32 |
11:02 ET | 600 | 3.315 |
11:06 ET | 150 | 3.31 |
11:08 ET | 100 | 3.32 |
11:09 ET | 100 | 3.32 |
11:11 ET | 500 | 3.31 |
11:13 ET | 2538 | 3.3 |
11:15 ET | 1550 | 3.305 |
11:18 ET | 500 | 3.29 |
11:20 ET | 100 | 3.3 |
11:22 ET | 500 | 3.295 |
11:24 ET | 1700 | 3.305 |
11:26 ET | 702 | 3.3 |
11:36 ET | 3614 | 3.31 |
11:38 ET | 14291 | 3.3 |
11:40 ET | 5713 | 3.31 |
11:42 ET | 10095 | 3.32 |
11:44 ET | 400 | 3.3 |
11:45 ET | 1274 | 3.29 |
11:49 ET | 922 | 3.29 |
11:51 ET | 2079 | 3.32 |
11:56 ET | 1097 | 3.32 |
12:00 ET | 200 | 3.33 |
12:02 ET | 10790 | 3.34 |
12:05 ET | 1009 | 3.35 |
12:07 ET | 930 | 3.339 |
12:09 ET | 307 | 3.335 |
12:12 ET | 300 | 3.33 |
12:14 ET | 138 | 3.335 |
12:16 ET | 3226 | 3.35 |
12:18 ET | 440 | 3.3459 |
12:20 ET | 401 | 3.35 |
12:21 ET | 130 | 3.35 |
12:23 ET | 404 | 3.35 |
12:27 ET | 100 | 3.36 |
12:30 ET | 302 | 3.35 |
12:32 ET | 6001 | 3.37 |
12:34 ET | 295 | 3.37 |
12:36 ET | 1140 | 3.37 |
12:38 ET | 257 | 3.3799 |
12:41 ET | 446 | 3.36 |
12:43 ET | 106 | 3.36 |
12:48 ET | 1741 | 3.36 |
12:50 ET | 629 | 3.35 |
12:52 ET | 506 | 3.36 |
12:54 ET | 293 | 3.36 |
01:01 ET | 200 | 3.35 |
01:03 ET | 334 | 3.36 |
01:08 ET | 440 | 3.36 |
01:10 ET | 100 | 3.36 |
01:14 ET | 200 | 3.36 |
01:15 ET | 453 | 3.37 |
01:17 ET | 200 | 3.38 |
01:19 ET | 100 | 3.375 |
01:21 ET | 1292 | 3.38 |
01:24 ET | 570 | 3.37 |
01:26 ET | 386 | 3.36 |
01:28 ET | 200 | 3.37 |
01:30 ET | 2802 | 3.35 |
01:32 ET | 3189 | 3.34 |
01:33 ET | 500 | 3.34 |
01:35 ET | 800 | 3.32 |
01:37 ET | 500 | 3.32 |
01:39 ET | 785 | 3.32 |
01:42 ET | 200 | 3.32 |
01:44 ET | 541 | 3.325 |
01:46 ET | 849 | 3.33 |
01:48 ET | 4199 | 3.34 |
01:50 ET | 133 | 3.33 |
01:51 ET | 6170 | 3.32 |
01:53 ET | 138 | 3.33 |
01:55 ET | 1385 | 3.33 |
01:57 ET | 498 | 3.33 |
02:00 ET | 1100 | 3.325 |
02:02 ET | 650 | 3.33 |
02:04 ET | 100 | 3.33 |
02:06 ET | 599 | 3.33 |
02:09 ET | 537 | 3.32 |
02:11 ET | 4234 | 3.32 |
02:13 ET | 475 | 3.335 |
02:18 ET | 259 | 3.335 |
02:20 ET | 331 | 3.33 |
02:22 ET | 200 | 3.33 |
02:24 ET | 527 | 3.34 |
02:26 ET | 331 | 3.345 |
02:27 ET | 200 | 3.35 |
02:29 ET | 100 | 3.3485 |
02:31 ET | 435 | 3.34 |
02:33 ET | 3470 | 3.3363 |
02:36 ET | 200 | 3.33 |
02:38 ET | 100 | 3.33 |
02:40 ET | 500 | 3.33 |
02:42 ET | 988 | 3.34 |
02:44 ET | 100 | 3.345 |
02:45 ET | 334 | 3.345 |
02:47 ET | 700 | 3.3437 |
02:49 ET | 100 | 3.345 |
02:51 ET | 200 | 3.345 |
02:54 ET | 100 | 3.34 |
02:58 ET | 593 | 3.35 |
03:00 ET | 351 | 3.35 |
03:02 ET | 564 | 3.35 |
03:03 ET | 4846 | 3.32 |
03:05 ET | 397 | 3.32 |
03:07 ET | 1106 | 3.33 |
03:09 ET | 2434 | 3.325 |
03:12 ET | 100 | 3.32 |
03:14 ET | 205 | 3.325 |
03:16 ET | 700 | 3.325 |
03:20 ET | 200 | 3.325 |
03:21 ET | 330 | 3.325 |
03:23 ET | 400 | 3.32 |
03:32 ET | 2027 | 3.315 |
03:36 ET | 830 | 3.315 |
03:38 ET | 1306 | 3.32 |
03:39 ET | 300 | 3.315 |
03:41 ET | 500 | 3.315 |
03:43 ET | 1100 | 3.31 |
03:45 ET | 2153 | 3.305 |
03:48 ET | 891 | 3.305 |
03:50 ET | 1135 | 3.305 |
03:52 ET | 13748 | 3.31 |
03:54 ET | 4827 | 3.31 |
03:56 ET | 3551 | 3.3199 |
03:57 ET | 1460 | 3.31 |
03:59 ET | 4805 | 3.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aldeyra Therapeutics Inc | 196.7M | -6.5x | --- |
Pyxis Oncology Inc | 194.9M | -2.4x | --- |
Rani Therapeutics Holdings Inc | 191.6M | -2.9x | --- |
Gossamer Bio Inc | 203.8M | -0.9x | --- |
Design Therapeutics Inc | 189.3M | -3.2x | --- |
Immutep Ltd | 284.8M | -7.7x | --- |
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $196.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-0.51 |
Book Value | $2.02 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.